In the competitive field of Material Analysis, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Material Analysis technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Material Analysis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Material Analysis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Material Analysis industry

EP3275313Device For Detecting And Evaluating Product-Specific Information Of Products Of The Food Processing Industry, And System Comprising Such A Device And Method Of Processing Products Of The Food Processing IndustryNORDISCHER MASCHINENBAU RUD. BAADER GMBH + CO. KGNov 14, 2024MAREL ICELAND EHF.
EP4232828Methods And Kits For Diagnosing Covid-19 DiseaseSTELLENBOSCH UNIVERSITYNov 7, 2024CLINICUM ST. GEORG GMBH & CO. KG
EP3495822Method For Assessing Acute Myocardial Infarction Based On Highly Sensitive Analysis Of Cardiac TroponinSINGULEX, INC.Sep 20, 2024JG OPPOSITIONS LIMITED
EP3855186A Method For Determining The Efficacy Of A Sars-Cov-2 VaccineEUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AGSep 4, 2024SIMMONS & SIMMONS LLP
EP3799958Pipette Tip And Uses And Methods ThereofENICOR GMBHAug 13, 2024VITROGENICS GMBH
EP3423591Nad(P)-Dependent Responsive Enzymes, Electrodes And Sensors, And Methods For Making And Using The SameABBOTT DIABETES CARE INC.Jul 31, 2024DEXCOM, INC.
EP3950959Detection Of Sars-Cov-2 In A Plurality Of Biological SamplesJOHANN-WOLFGANG-GOETHE-UNIVERSITÄT FRANKFURT AM MAINJul 23, 2024SYNLAB HOLDING DEUTSCHLAND GMBH
EP3436822Decision Tree Based Systems And Methods For Estimating The Risk Of Acute Coronary SyndromeABBOTT LABORATORIESJul 16, 2024ROCHE DIAGNOSTICS INTERNATIONAL AG
EP3221695Parallel-Processing Systems And Methods For Highly Scalable Analysis Of Biological Sequence DataTHE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITALJun 27, 2024MARKS & CLERK LLP
EP3634463Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALS INC.Jun 27, 2024GALENICUM HEALTH S.L.U.

To stay ahead in the competitive Material Analysis industry, companies are constantly innovating. Here are the top patents facing oppositions in the Material Analysis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2653873Aug 24, 2022Compositions And Uses For Treating Multiple SclerosisBIOGEN MA INC.14
EP2971040Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS, INC.10
EP3322731Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL-MYERS SQUIBB COMPANY9
EP2708559Mar 28, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA6
EP3634463Jan 10, 2024Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALS INC.5
EP2784084Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofNOVARTIS PHARMA AG5
EP2682397Apr 19, 2017Prodrugs Of Phosphonate Nucleotide Analogues And Methods For Selecting And Making SameGILEAD SCIENCES, INC.5
EP2708558Mar 21, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA5
EP3178483Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO4
EP3647783Dec 21, 2022Identifying Patient Response To S1P Receptor Modulator AdministrationNOVARTIS AG4